Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
4
|
pubmed:dateCreated |
1994-5-9
|
pubmed:abstractText |
Small-scale clinical investigations have demonstrated that single doses of beta-blocking agents can improve left ventricular function in heart failure from idiopathic dilated cardiomyopathy (IDC). The purpose of this multicenter clinical trial was to determine the dose-effect characteristics of beta-blockade in a heart failure population that includes ischemic dilated cardiomyopathy (ISCD).
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Apr
|
pubmed:issn |
0009-7322
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
89
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
N
|
pubmed:pagination |
1632-42
|
pubmed:dateRevised |
2007-11-15
|
pubmed:meshHeading |
pubmed-meshheading:7908610-Adrenergic beta-Antagonists,
pubmed-meshheading:7908610-Cardiomyopathy, Dilated,
pubmed-meshheading:7908610-Dose-Response Relationship, Drug,
pubmed-meshheading:7908610-Double-Blind Method,
pubmed-meshheading:7908610-Female,
pubmed-meshheading:7908610-Heart Failure,
pubmed-meshheading:7908610-Humans,
pubmed-meshheading:7908610-Male,
pubmed-meshheading:7908610-Middle Aged,
pubmed-meshheading:7908610-Propanolamines,
pubmed-meshheading:7908610-Prospective Studies,
pubmed-meshheading:7908610-Ventricular Function, Left
|
pubmed:year |
1994
|
pubmed:articleTitle |
Dose-response of chronic beta-blocker treatment in heart failure from either idiopathic dilated or ischemic cardiomyopathy. Bucindolol Investigators.
|
pubmed:affiliation |
Division of Cardiology, University of Colorado Health Sciences Center, Denver 80262.
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Comparative Study,
Randomized Controlled Trial,
Research Support, Non-U.S. Gov't,
Multicenter Study
|